Helius Medical Technologies Inc (HSDT) Ordinary Shares - Class A

Sell:$14.06Buy:$14.25$0.31 (2.15%)

Prices delayed by at least 15 minutes
Sell:$14.06
Buy:$14.25
Change:$0.31 (2.15%)
Prices delayed by at least 15 minutes
Sell:$14.06
Buy:$14.25
Change:$0.31 (2.15%)
Prices delayed by at least 15 minutes

Company Information

About this company

Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.

Key people

Joseph Chee
Executive Chairman of the Board
Dane C. Andreeff
President, Chief Executive Officer, Director
Jeffrey S. Mathiesen
Chief Financial Officer, Treasurer, Secretary, Director
Antonella Favit-Van Pelt
Chief Medical Officer
Paul Buckman
Independent Director
Sherrie Perkins
Independent Director
Edward M. Straw
Independent Director
Blane Walter
Independent Director
Click to see more

Key facts

  • EPIC
    HSDT
  • Location
    United States
  • Sector
    Financial
  • Industry
    Misc. Financial Services
  • ISIN
    US42328V8761
  • Market cap
    $529.07m
  • Employees
    21
  • Shares in issue
    38.90m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.